Literature DB >> 15082527

Distinct aerobic and hypoxic mechanisms of HIF-alpha regulation by CSN5.

Lynne Bemis1, Denise A Chan, Carla V Finkielstein, Lin Qi, Patrick D Sutphin, Xiaojiang Chen, Kurt Stenmark, Amato J Giaccia, Wayne Zundel.   

Abstract

Mammalian oxygen homeostasis is dependent on the HIF family of transcription factors. The CSN subunit, CSN5, binds both the CODD of HIF-1 alpha and the pVHL tumor suppressor. High CSN5 expression generates a pVHL-independent form of CSN5 that stabilizes HIF-1 alpha aerobically by inhibiting HIF-1 alpha prolyl-564 hydroxylation. Aerobic CSN5 association with HIF-1 alpha occurs independently of the CSN holocomplex, leading to HIF-1 alpha stabilization independent of Cullin 2 deneddylation. CSN5 weakly associates with HIF-1 alpha under hypoxia, but is required for optimal hypoxia-mediated HIF-1 alpha stabilization. These results indicate that CSN5 regulates aerobic as well as hypoxic HIF-1 alpha stability by different mechanisms during oncogenesis.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15082527      PMCID: PMC387414          DOI: 10.1101/gad.1180104

Source DB:  PubMed          Journal:  Genes Dev        ISSN: 0890-9369            Impact factor:   11.361


  11 in total

Review 1.  The COP9 signalosome: an assembly and maintenance platform for cullin ubiquitin ligases?

Authors:  Dieter A Wolf; Chunshui Zhou; Susan Wee
Journal:  Nat Cell Biol       Date:  2003-12       Impact factor: 28.824

2.  An intact NEDD8 pathway is required for Cullin-dependent ubiquitylation in mammalian cells.

Authors:  Michael Ohh; William Y Kim; Javid J Moslehi; Yuzhi Chen; Vincent Chau; Margaret A Read; William G Kaelin
Journal:  EMBO Rep       Date:  2002-01-29       Impact factor: 8.807

3.  Phosphatidylinositol 3-kinase signaling controls levels of hypoxia-inducible factor 1.

Authors:  B H Jiang; G Jiang; J Z Zheng; Z Lu; T Hunter; P K Vogt
Journal:  Cell Growth Differ       Date:  2001-07

4.  von Hippel-Lindau protein mutants linked to type 2C VHL disease preserve the ability to downregulate HIF.

Authors:  M A Hoffman; M Ohh; H Yang; J M Klco; M Ivan; W G Kaelin
Journal:  Hum Mol Genet       Date:  2001-05-01       Impact factor: 6.150

5.  Jab1 interacts directly with HIF-1alpha and regulates its stability.

Authors:  Moon-Kyoung Bae; Mee-Young Ahn; Joo-Won Jeong; Myung-Ho Bae; You Mie Lee; Soo-Kyung Bae; Jong-Wan Park; Kwang-Rok Kim; Kyu-Won Kim
Journal:  J Biol Chem       Date:  2001-11-13       Impact factor: 5.157

Review 6.  The von Hippel-Lindau tumor suppressor protein: new insights into oxygen sensing and cancer.

Authors:  William Kim; William G Kaelin
Journal:  Curr Opin Genet Dev       Date:  2003-02       Impact factor: 5.578

Review 7.  Investigating hypoxic tumor physiology through gene expression patterns.

Authors:  Nicholas C Denko; Lucrezia A Fontana; Karen M Hudson; Patrick D Sutphin; Soumya Raychaudhuri; Russ Altman; Amato J Giaccia
Journal:  Oncogene       Date:  2003-09-01       Impact factor: 9.867

8.  Structural basis for the recognition of hydroxyproline in HIF-1 alpha by pVHL.

Authors:  Wai-Ching Hon; Michael I Wilson; Karl Harlos; Timothy D W Claridge; Christopher J Schofield; Christopher W Pugh; Patrick H Maxwell; Peter J Ratcliffe; David I Stuart; E Yvonne Jones
Journal:  Nature       Date:  2002-06-05       Impact factor: 49.962

9.  Role of prolyl hydroxylation in oncogenically stabilized hypoxia-inducible factor-1alpha.

Authors:  Denise A Chan; Patrick D Sutphin; Nicholas C Denko; Amato J Giaccia
Journal:  J Biol Chem       Date:  2002-08-16       Impact factor: 5.157

10.  Retrovirus-delivered siRNA.

Authors:  Eric Devroe; Pamela A Silver
Journal:  BMC Biotechnol       Date:  2002-08-28       Impact factor: 2.563

View more
  31 in total

1.  Jab1 mediates protein degradation of the Rad9-Rad1-Hus1 checkpoint complex.

Authors:  Jin Huang; Honglin Yuan; Chongyuan Lu; Ximeng Liu; Xu Cao; Mei Wan
Journal:  J Mol Biol       Date:  2007-06-04       Impact factor: 5.469

2.  Nur77 upregulates HIF-alpha by inhibiting pVHL-mediated degradation.

Authors:  Bu Yeon Kim; Hyungsoo Kim; Eun Jung Cho; Hong Duk Youn
Journal:  Exp Mol Med       Date:  2008-02-29       Impact factor: 8.718

Review 3.  The emerging roles of Jab1/CSN5 in cancer.

Authors:  Lin Wang; Jun-Nian Zheng; Dong-Sheng Pei
Journal:  Med Oncol       Date:  2016-07-13       Impact factor: 3.064

4.  Amplification of tumor hypoxic responses by macrophage migration inhibitory factor-dependent hypoxia-inducible factor stabilization.

Authors:  Millicent Winner; Albert C Koong; Beatriz E Rendon; Wayne Zundel; Robert A Mitchell
Journal:  Cancer Res       Date:  2007-01-01       Impact factor: 12.701

Review 5.  Macrophage migration inhibitory factor manipulation and evaluation in tumoral hypoxic adaptation.

Authors:  Millicent Winner; Lin Leng; Wayne Zundel; Robert A Mitchell
Journal:  Methods Enzymol       Date:  2007       Impact factor: 1.600

6.  COP9 signalosome complex subunit 5, an IFT20 binding partner, is essential to maintain male germ cell survival and acrosome biogenesis†.

Authors:  Qian Huang; Hong Liu; Jing Zeng; Wei Li; Shiyang Zhang; Ling Zhang; Shizhen Song; Ting Zhou; Miriam Sutovsky; Peter Sutovsky; Ruggero Pardi; Rex A Hess; Zhibing Zhang
Journal:  Biol Reprod       Date:  2020-02-12       Impact factor: 4.285

Review 7.  Mechanisms of macrophage migration inhibitory factor (MIF)-dependent tumor microenvironmental adaptation.

Authors:  Beatriz E Rendon; Sharon S Willer; Wayne Zundel; Robert A Mitchell
Journal:  Exp Mol Pathol       Date:  2009-01-07       Impact factor: 3.362

8.  Drosophila genome-wide RNAi screen identifies multiple regulators of HIF-dependent transcription in hypoxia.

Authors:  Andrés Dekanty; Nuria M Romero; Agustina P Bertolin; María G Thomas; Claudia C Leishman; Joel I Perez-Perri; Graciela L Boccaccio; Pablo Wappner
Journal:  PLoS Genet       Date:  2010-06-24       Impact factor: 5.917

9.  JAB1/CSN5: a new player in cell cycle control and cancer.

Authors:  Terry J Shackleford; Francois X Claret
Journal:  Cell Div       Date:  2010-10-18       Impact factor: 5.130

10.  JAB1-STAT3 activation loop is associated with recurrence following 5-fluorouracil-based adjuvant chemotherapy in human colorectal cancer.

Authors:  Naruji Kugimiya; Arata Nishimoto; Tohru Hosoyama; Koji Ueno; Yoshihiro Takemoto; Eijiro Harada; Tadahiko Enoki; Kimikazu Hamano
Journal:  Oncol Lett       Date:  2017-09-18       Impact factor: 2.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.